| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2405542 | Vaccine | 2009 | 7 Pages |
Abstract
In preclinical studies, they have demonstrated a high degree of immunogenicity, while overcoming pitfalls faced by other viral vectors. These findings, combined with recent progress in large scale LV production/purification, make this strategy worth considering for further vaccine development.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Franck Lemiale, Nikolay Korokhov,